Thorsten Hagemann

Stockley Park
Uxbridge, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.

Corrigendum: Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.

Journal: Nature

Published: April 07, 2016

Immune monitoring technology primer: immunoprofiling of antigen-stimulated blood.

Immune monitoring technology primer: immunoprofiling of antigen-stimulated blood.

Journal: Journal for immunotherapy of cancer

Published: March 01, 2016

Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.

Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.

Journal: Gastroenterology

Published: September 20, 2015

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

Journal: Oncoimmunology

Published: September 16, 2015

The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1).

The MEK1/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 27, 2015

A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer.

A vaccinia virus armed with interleukin-10 is a promising therapeutic agent for treatment of murine pancreatic cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 23, 2014

PD-L1 expression in small cell neuroendocrine carcinomas.

PD-L1 expression in small cell neuroendocrine carcinomas.

Journal: European journal of cancer (Oxford, England : 1990)

Published: July 17, 2014

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma.

Journal: Genome medicine

Published: June 26, 2014

Haematopoietic focal adhesion kinase deficiency alters haematopoietic homeostasis to drive tumour metastasis.

Haematopoietic focal adhesion kinase deficiency alters haematopoietic homeostasis to drive tumour metastasis.

Journal: Nature communications

Published: March 13, 2014

Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.

Dual-action combination therapy enhances angiogenesis while reducing tumor growth and spread.

Journal: Cancer cell

Published: February 24, 2014

ADAM8 as a drug target in pancreatic cancer.

ADAM8 as a drug target in pancreatic cancer.

Journal: Nature communications

Published: February 19, 2014

Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway.

Tumour Microenvironment: Overview with an Emphasis on the Colorectal Liver Metastasis Pathway.

Journal: Cancer microenvironment : official journal of the International Cancer Microenvironment Society

Published: January 13, 2014

Showing 1-12 of 30

Last Updated: 09/26/2026